Literature DB >> 7324123

The maximum density of anopheline mosquitoes that can be permitted in the absence of continuing transmission of filariasis.

R H Webber, B A Southgate.   

Abstract

Using two years of mosquito collections from two fixed stations on Guadalcanal it was possible to compare the average man-biting rate with the prevalence of microfilaraemia. One area was found to be free of infection while the other still had one positive case. The DDT residual spraying had caused a change in biting habits of A. farauti No. 1 allowing a greater density of mosquitoes to bite man at times when they had lower microfilaria densities. This difference was compared with the pre-spray density so that the maximum permissible number of mosquitoes biting man without transmission of filariasis taking place, could be calculated. A theoretical value for m of 19.84 had been worked out previously; this study gave a corrected observed value of m of approximately 20, very close to the calculated theoretical value. The situation studied here probably showed incomplete interruption of transmission, so it was considered preferrable to recommend a figure of 0.66 average vector man-biting rate per hour indoors for the critical value.

Entities:  

Mesh:

Year:  1981        PMID: 7324123     DOI: 10.1016/0035-9203(81)90185-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  Bancroftian filariasis in Pondicherry, south India: 2. Epidemiological evaluation of the effect of vector control.

Authors:  S Subramanian; S P Pani; P K Das; P K Rajagopalan
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

2.  Past exposure and the dynamics of lymphatic filariasis infection in young children.

Authors:  A Srividya; P K Das; S Subramanian; K D Ramaiah; B T Grenfell; E Michael; D A Bundy
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

3.  The impact of a filariasis control program on Lihir Island, Papua New Guinea.

Authors:  Oriol Mitjà; Raymond Paru; Russell Hays; Lysaght Griffin; Nedley Laban; Mellie Samson; Quique Bassat
Journal:  PLoS Negl Trop Dis       Date:  2011-08-23

4.  The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.

Authors:  Dziedzom K de Souza; Rashid Ansumana; Santigie Sessay; Abu Conteh; Benjamin Koudou; Maria P Rebollo; Joseph Koroma; Daniel A Boakye; Moses J Bockarie
Journal:  Parasit Vectors       Date:  2015-09-24       Impact factor: 3.876

5.  A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands.

Authors:  Humpress Harrington; James Asugeni; Christopher Jimuru; John Gwalaa; Elmer Ribeyro; Richard Bradbury; Hayley Joseph; Wayne Melrose; David MacLaren; Rick Speare
Journal:  Parasit Vectors       Date:  2013-07-26       Impact factor: 3.876

6.  How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector?

Authors:  Christopher M Stone; Steve W Lindsay; Nakul Chitnis
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

7.  Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.

Authors:  Pelagie M Boko-Collins; Aurore Ogouyemi-Hounto; Elvire G Adjinacou-Badou; Laurinda Gbaguidi-Saizonou; Nissou Ines Dossa; Aboudou Dare; Moudachirou Ibikounle; Kathryn L Zoerhoff; Daniel A Cohn; Wilfrid Batcho
Journal:  Parasit Vectors       Date:  2019-05-30       Impact factor: 4.047

8.  No evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and Liberia.

Authors:  Dziedzom K de Souza; Santigie Sesay; Marnijina G Moore; Rashid Ansumana; Charles A Narh; Karsor Kollie; Maria P Rebollo; Benjamin G Koudou; Joseph B Koroma; Fatorma K Bolay; Daniel A Boakye; Moses J Bockarie
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.